Rappel Ou Alerte De Sécurité sur Breezeway® 10F Adelante Pod, distributed by Medtronic as the ARRIVE ™ Braided Transeptal Pod.

Selon Agencia Española de Medicamentos y Productos Sanitarios (Via FOI), ce/cet/cette rappel ou alerte de sécurité concerne un dispositif en/au/aux/à Spain qui a été fabriqué par Medtronic.

Qu'est-ce que c'est?

Les alertes fournissent des informations importantes et des recommandations concernant les dispositifs médicaux. Le fait qu'une alerte soit émise ne signifie pas nécessairement qu'un dispositif soit dangereux. Les alertes de sécurité, qui sont envoyées tant aux travailleurs du secteur médical qu'aux utilisateurs de ces dispositifs, peuvent inclure des rappels. Elles peuvent être rédigées par des fabricants mais aussi par des autorités en charge de la santé.

En savoir plus sur les données ici
  • Type d'événement
    Recall / Safety Alert
  • Date
    2016-11-24
  • Pays de l'événement
  • Source de l'événement
    AEMPSVFOI
  • Notes / Alertes
    The data from Spain is current through June 2018. All of the data comes from Agencia Española de Medicamentos y Productos Sanitarios, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Spain.
  • Notes supplémentaires dans les données
  • Action
    Removal from the market of certain models and lots of the Breezeway® 10F Adelante® Pod, manufactured by Oscor Inc., USA, distributed by Medtronic as the ARRIVE ™ Transeptal Braided Pod, due to the possibility of detaching a fragment of the inner tissue from the sheath when inserting the dilator during preparation of the sheath for use

Manufacturer

  • Société-mère du fabricant (2017)
  • Commentaire du fabricant
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source
    AEMPSVFOI